AZ St.-Elisabeth Herentals VZW

At AZ St.-Elisabeth Herentals VZW, clinical research in rheumatoid arthritis focuses on improving long-term disease control, reducing symptom burden, and refining treatment strategies for people living with inflammatory joint disease.

• Testing more effective ways to adjust and taper treatment in rheumatoid arthritis
• Comparing treatment approaches to improve remission and overall disease outcomes in early rheumatoid arthritis
• Following patients over time to understand safety and lasting benefit of current care strategies

These studies aim to support better day-to-day disease management and more personalized care for patients seen at the site.

Research in cardiovascular diseases includes studies in heart failure with preserved or mildly reduced ejection fraction linked with obesity, with a focus on improving outcomes for patients at higher risk of hospital visits and cardiovascular death.

• Evaluating a new treatment approach added to standard care for heart failure
• Studying whether therapy can reduce hospitalizations, urgent visits, and death from cardiovascular disease
• Targeting patients with HFpEF and HFmrEF who also have elevated body mass index

This work reflects a broader effort to improve symptom control and clinical stability in complex heart failure populations.

The site also contributes to oncology-related research in neoplasms, especially conditions that may progress toward multiple myeloma. These studies are designed to better understand early disease and explore new ways to target abnormal plasma cells.

• Assessing a new therapy for high-risk monoclonal gammopathy of undetermined significance
• Studying treatment options for smoldering multiple myeloma
• Evaluating whether therapy can remove abnormal plasma cells before more advanced disease develops

At this Belgian hospital site, the research aims to improve early intervention and expand treatment possibilities in plasma cell-related blood cancers.